Curating the Way to Better Determinants of Genetic Risk
Overview
Authors
Affiliations
Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer.
Elkholi I, Di Iorio M, Fahiminiya S, Arcand S, Han H, Nogue C Sci Rep. 2021; 11(1):2409.
PMID: 33510186 PMC: 7844268. DOI: 10.1038/s41598-021-81106-w.
Consistency of and Variant Classifications Among Clinical Diagnostic Laboratories.
Lincoln S, Yang S, Cline M, Kobayashi Y, Zhang C, Topper S JCO Precis Oncol. 2017; 1.
PMID: 28782058 PMC: 5542009. DOI: 10.1200/PO.16.00020.
Beckmann J, Lew D Genome Med. 2016; 8(1):134.
PMID: 27993174 PMC: 5165712. DOI: 10.1186/s13073-016-0388-7.
DATA SHARING AND REPRODUCIBLE CLINICAL GENETIC TESTING: SUCCESSES AND CHALLENGES.
Yang S, Cline M, Zhang C, Paten B, Lincoln S Pac Symp Biocomput. 2016; 22:166-176.
PMID: 27896972 PMC: 5340191. DOI: 10.1142/9789813207813_0017.
Outcomes of retesting BRCA negative patients using multigene panels.
Yadav S, Reeves A, Campian S, Paine A, Zakalik D Fam Cancer. 2016; 16(3):319-328.
PMID: 27878467 DOI: 10.1007/s10689-016-9956-7.